TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183 | -3.7% | 4,822 | -3.6% | 0.00% | – |
| Q2 2023 | $190 | – | 5,002 | +250000.0% | 0.00% | – |
| Q2 2022 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 2 | -50.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 4 | -96.2% | 0.00% | – |
| Q3 2021 | $6,000 | -72.7% | 106 | -64.7% | 0.00% | – |
| Q2 2021 | $22,000 | -88.5% | 300 | -88.5% | 0.00% | – |
| Q1 2021 | $192,000 | -76.4% | 2,600 | -76.6% | 0.00% | – |
| Q4 2020 | $815,000 | +180.1% | 11,100 | +109.4% | 0.00% | – |
| Q3 2020 | $291,000 | -46.0% | 5,300 | -34.6% | 0.00% | – |
| Q2 2020 | $539,000 | +91.1% | 8,100 | +117.0% | 0.00% | – |
| Q3 2019 | $282,000 | -9.9% | 3,732 | +1.8% | 0.00% | – |
| Q2 2019 | $313,000 | +77.8% | 3,666 | +124.4% | 0.00% | – |
| Q1 2019 | $176,000 | +72.5% | 1,634 | +36.2% | 0.00% | – |
| Q4 2018 | $102,000 | -91.2% | 1,200 | -89.8% | 0.00% | -100.0% |
| Q3 2018 | $1,154,000 | +29.5% | 11,733 | +52.4% | 0.00% | 0.0% |
| Q2 2018 | $891,000 | -25.4% | 7,700 | -36.4% | 0.00% | 0.0% |
| Q1 2018 | $1,194,000 | +275.5% | 12,101 | +298.3% | 0.00% | – |
| Q4 2017 | $318,000 | -87.8% | 3,038 | -86.9% | 0.00% | -100.0% |
| Q3 2017 | $2,612,000 | -26.9% | 23,172 | -27.4% | 0.00% | -25.0% |
| Q2 2017 | $3,575,000 | -3.8% | 31,903 | +0.1% | 0.00% | 0.0% |
| Q1 2017 | $3,718,000 | +19.2% | 31,882 | +7.6% | 0.00% | +33.3% |
| Q4 2016 | $3,119,000 | +203.4% | 29,621 | +218.6% | 0.00% | +200.0% |
| Q3 2016 | $1,028,000 | -38.5% | 9,296 | -19.0% | 0.00% | -50.0% |
| Q2 2016 | $1,672,000 | +420.9% | 11,479 | +410.6% | 0.00% | – |
| Q1 2016 | $321,000 | -88.9% | 2,248 | -88.0% | 0.00% | -100.0% |
| Q4 2015 | $2,893,000 | +5686.0% | 18,785 | +5267.1% | 0.00% | – |
| Q3 2015 | $50,000 | +733.3% | 350 | +695.5% | 0.00% | – |
| Q2 2015 | $6,000 | -96.0% | 44 | -95.9% | 0.00% | – |
| Q1 2015 | $151,000 | -19.3% | 1,074 | -15.0% | 0.00% | – |
| Q4 2014 | $187,000 | +125.3% | 1,263 | +133.0% | 0.00% | – |
| Q3 2014 | $83,000 | -95.3% | 542 | -96.6% | 0.00% | -100.0% |
| Q1 2014 | $1,754,000 | +556.9% | 15,798 | +478.9% | 0.00% | – |
| Q4 2013 | $267,000 | +80.4% | 2,729 | +3.2% | 0.00% | – |
| Q2 2013 | $148,000 | – | 2,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |